22 results on '"Castagna, Luca"'
Search Results
2. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
3. Micafungin Versus Fluconazole Or Itraconazole For Prophylaxis Against Invasive Fungal Infections During Neutropenia In Patients Undergoing Haplo-Identical Hematopoietic Stem Cell Transplantation
4. Use Of Unrelated Donors In Elderly Patients (age >60 years) Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation For Hematologic Malignancies
5. Comparison Of Umbilical Cord Blood and Haploidentical Donor Grafts In Adults With High Risk Hematologic Diseases After Fludarabine Cyclophosphamide and TBI 2 Gy Based Reduced-Intensity Conditioning Regimen Stem Cell Transplantation
6. Plasma extracellular vesicles in cytomegalovirus reactivation after haploidentical stem cell transplantation
7. Reduced Relapse and Improved Survival in Chemosensitive Hodgkin Lymphoma Patients Undergoing Haploidentical Related Donor Compared to HLA-Identical Donor Transplantation
8. Donor specific anti-hla antibodies (DSA) in haploidentical stem cell transplantation with post transplant cyclophosphamide: Risk of graft failure, poor graft function and impact on outcomes
9. Feasibility of Modified CD45RA Negative Donor Lymphocytes Infusion after Haploidentical Stem Cell Transplantation (HAPLO-SCT) with Post-transplantation Cyclophosphamide (PT-Cy) in Patients with Hematological Malignancies
10. Efficacy and Safety of Donor Lymphocyte Infusions for Patients affected by Advanced Lymphoid Malignancies after Allogeneic Stem Cell Transplantation: A Retrospective Study
11. Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: Outcome strongly correlates with disease status; a report from the EBMT acute leukemia working party
12. NON-FIRST DEGREE RELATIVE DONOR AND THE OUTCOME OF PATIENTS RECEIVING T CELL-REPLETE HAPLOIDENTICAL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
13. Gvhd after PBSC-Haploidentical Stem Cell Transplantation (Haplo-SCT) with Post Transplantation-Cyclophosphamide (PT-Cy)
14. The Novel Calcium Release-Activated Calcium (CRAC) Channel Inhibitor RP4010 Exerts Potent Antitumor Effects in NOD/SCID/IL2Rg(-/-) Mice with Diffuse Large B Cell Lymphoma (DLBCL) Cell Line Xenografts
15. The Minnesota Refined Acute GVHD Score Predicts Response to Initial Therapy, Survival and Non-Relapse Mortality after Haploidentical Transplantation with Post-Transplant Cyclophosphamide
16. Checkpoint inhibitor treatment before haploidentical transplantation in relapsed or refractory Hodgkin Lymphoma (HL) patients is associated with higher PFS without increased toxicities
17. Thiotepa, Fludarabine and Busulfan conditioning regimen before T-cell replete haploidentical transplantation with post-transplant cyclophosphamide for AML and MDS : a bicentric experience of 109 patients
18. Post-transplant Cyclophosphamide in One-Antigen Mismatched Unrelated Donor Transplantation Versus Haploidentical Transplantation: A Retrospective Study on Behalf of The Acute Leukemia Working Party of The EBMT
19. Primary Antifungal Prophylaxis with caspofungin after haploidentical transplantation with post-transplant cyclophosphamide: a retrospective analysis
20. Upregulation of Cereblon Expression By the DNA Methyltransferase Inhibitor Azacytidine Strongly Enhances Lenalidomide Cytotoxicity in Germinal Center B-Cell-like (GCB) and Activated B-Cell-like (ABC) Diffuse Large B-Cell Lymphoma (DLBCL)
21. New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?
22. Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.